Abstract

Abstract

Background: An upper limb arteriovenous (AV) fistula is the access of choice for haemodialysis (HD). There have been few reports of saphenofemoral AV fistulas (SFAVF) over the last 10-20 years because of previous suggestions of poor patencies and needling difficulties. Here, we describe our clinical experience with SFAVF.

Methods: SFAVFs were evaluated using the following variables: immediate results, early and late complications, intraoperative and postoperative complications (up to day 30), efficiency of the fistula after the onset of needling and complications associated to its use.

Results: Fifty-six SFAVF fistulas were created in 48 patients. Eight patients had two fistulas: 8 patent (16%), 10 transplanted (20%), 12 deaths (24%), 1 low flow (2%) and 20 thrombosis (39%) (first two months of preparation). One patient had severe hypotension during surgery, which caused thrombosis of the fistula, which was successfully thrombectomised, four thrombosed fistulae were successfully thrombectomised and revised on the first postoperative day. After 59 months of follow-up, primary patency was 44%.

Conclusion: SFAVF is an adequate alternative for patients without the possibility for other access in the upper limbs, allowing efficient dialysis with good long-term patency with a low complication rate.

Details

Title
Saphenofemoral arteriovenous fistula as hemodialysis access
Author
Correa, João A; de Abreu, Luiz Carlos; Pires, Adilson C; Breda, João R; Yamazaki, Yumiko R; Fioretti, Alexandre C; Valenti, Vitor E; Vanderlei, Luiz Carlos M; Junior, Hugo Macedo; Colombari, Eduardo; Miranda, Fausto, Junior
Pages
28
Publication year
2010
Publication date
2010
Publisher
BioMed Central
e-ISSN
14712482
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
902208377
Copyright
© 2010 Correa et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.